Submitted by mphilemon@resea... on Thu, 02/11/2010 - 15:51
Oral Bisphosphonates and Breast Cancer — Prospective Results from the Women’s Health Initiative (WHI)
Slides from a presentation at SABCS 2009 and transcribed comments from a recent interview with Rowan T Chlebowski, MD, PhD (12/30/09)
Dr Chlebowski is Professor of Medicine at the David Geffen School of Medicine at UCLA and Chief of the Division of Medical Oncology and Hematology at Harbor-UCLA Medical Center in Torrance, California.
Presentation discussed in this issue:
Chlebowski RT et al. Oral bisphosphonate and breast cancer: Prospective results from the Women’s Health Initiative (WHI). San Antonio Breast Cancer Symposium 2009;Abstract 21.
Go to previous Journal Club Go to next Journal Club